Marcelo Barboza - Diagnsticos Director

DASA3 Stock  BRL 4.70  0.01  0.21%   

Director

Mr. Marcelo Noll Barboza serves as Director at DIAGNOSTICOS DA AMERICA S.A. since April 23 2015. He was Chief Executive Financial and Investor Relations Officer and Member of the Executive Board of Diagnosticos da America SA from September 16 2008 to April 27 2012. He has held the Chief Financial and Investor Relations posts since February 13 2012 and was CEO and Member of the Company Executive Board since September 16 2008. From 2004 to 2008 he worked for GE Healthcare Latam where his last position was Vice President. He was Director of Bradespar SA between 2001 and 2003 and later became General Director of Investshop Corretora between 1999 and 2001. He holds Bachelors degrees in Electric Engineering and Business Administration both from Universidade Federal do Rio Grande do Sul as well as an M.B.A. degree from the Harvard Business School. since 2015.
Age 46
Tenure 9 years
Professional MarksMBA
Phone55 11 4197 5500
Webhttps://www.dasa3.com.br

Diagnsticos Management Efficiency

The company has return on total asset (ROA) of 0.0224 % which means that it generated a profit of $0.0224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0458) %, meaning that it generated substantial loss on money invested by shareholders. Diagnsticos' management efficiency ratios could be used to measure how well Diagnsticos manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 6.97 B in total debt with debt to equity ratio (D/E) of 97.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Diagnsticos da Amrica has a current ratio of 1.55, which is within standard range for the sector. Debt can assist Diagnsticos until it has trouble settling it off, either with new capital or with free cash flow. So, Diagnsticos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Diagnsticos da Amrica sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Diagnsticos to invest in growth at high rates of return. When we think about Diagnsticos' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Marcio SchettiniPorto Seguro SA
53
Walter JanssenGrendene SA
59
Affonso PastoreM Dias Branco
78
Oswaldo AssisGrendene SA
65
Mailson NobregaGrendene SA
73
Lucia HauptmannPorto Seguro SA
50
Maria BrancoM Dias Branco
83
Francisco MaiaM Dias Branco
58
Evandro CouraPorto Seguro SA
56
Ricardo WeissM Dias Branco
58
Bruno GarfinkelPorto Seguro SA
40
Renato OchmanGrendene SA
55
Fernando LottenbergPorto Seguro SA
55
Caio DavidPorto Seguro SA
45
Pedro CerizePorto Seguro SA
48
Fernando IunesM Dias Branco
50
Guilherme LaagerM Dias Branco
60
Diagnsticos da Amrica S.A. provides diagnostic test services in Latin America. Diagnsticos da Amrica S.A. is a subsidiary of Cromossomo Participaes II S.A. DASA ON operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange. Diagnsticos da Amrica (DASA3) is traded on Sao Paulo Exchange in Brazil and employs 24 people.

Management Performance

Diagnsticos da Amrica Leadership Team

Elected by the shareholders, the Diagnsticos' board of directors comprises two types of representatives: Diagnsticos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnsticos. The board's role is to monitor Diagnsticos' management team and ensure that shareholders' interests are well served. Diagnsticos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnsticos' outside directors are responsible for providing unbiased perspectives on the board's policies.
Ricardo Orlando, Chief Information Technology
Fabio Cunha, Chief Legal & Compliance Officer
Pedro Bueno, Chief Executive Officer, Director
Ricardo SIlva, Private and Hospitals Businesses Officer
Oscar Bernardes, Independent Vice Chairman of the Board
Carlos Neto, Chief Director
Romeu Domingues, Chairman of the Board
Carlos Aquino, Accounting and Infrastructure Officer, Member of the Executive Board
Carlos Jorge, Chief Administrative and Finance Officer, Investor Relations Officer
Adriano Lima, Executive Vice President of Human Resources
Leonardo Vedolin, Director of RDI
Fbio Cunha, Chief Officer
Lilian Lira, Legal Officer, Member of the Executive Board
Octavio Silva, Member of the Executive Board, Vice President of Operations
Emerson Gasparetto, Radiology and Graphic Methods Officer, Member of the Executive Board
Marcelo Barboza, Director
Paulo CattaPreta, Member of the Executive Board
Alexandre Barros, Independent Director
Linaldo Vilar, Director of Production
Henrique Jager, Independent Director
Gustavo Campana, Medical Director of Clinical Analysis
Linaldo Junior, Chief Officer
Antonio Gaeta, Member of the Executive Board, Executive Vice President of Business
Felipe Guimaraes, Chief Officer

Diagnsticos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagnsticos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Diagnsticos

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diagnsticos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnsticos will appreciate offsetting losses from the drop in the long position's value.

Moving together with Diagnsticos Stock

  0.86ACNB34 Accenture plcPairCorr

Moving against Diagnsticos Stock

  0.82AMZO34 Amazon IncPairCorr
  0.73JDCO34 JD IncPairCorr
  0.73BERK34 Berkshire HathawayPairCorr
  0.71WALM34 Walmart SplitPairCorr
  0.69TGTB34 TargetPairCorr
The ability to find closely correlated positions to Diagnsticos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diagnsticos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diagnsticos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diagnsticos da Amrica to buy it.
The correlation of Diagnsticos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diagnsticos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diagnsticos da Amrica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diagnsticos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Diagnsticos da Amrica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Diagnsticos da Amrica information on this page should be used as a complementary analysis to other Diagnsticos' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Diagnsticos Stock analysis

When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Please note, there is a significant difference between Diagnsticos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Diagnsticos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Diagnsticos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.